Hims & Hers Health (HIMS) Other financing activities (2019 - 2026)
Hims & Hers Health (HIMS) reported Other financing activities of $5.0 million for Q1 2026, up 27.49% on a YoY basis from $3.9 million in Q1 2025, and up 44.32% sequentially from $3.5 million in Q4 2025.
Hims & Hers Health (HIMS) Other financing activities (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Other financing activities data on file, last reported at $5.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 27.49% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (down 70.52% YoY), and the FY2025 full-year result was $6.4 million, down 75.84% from the prior year.
- Other financing activities advanced to $5.0 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $16.9 million in Q3 2024 to a low of -$3.4 million in Q2 2024.
- A 5-year average of $2.7 million and a median of $891000.0 in 2022 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 1969.39% in 2024, while the deepest fall reached 628.02% in 2024.
- Tracing HIMS's Other financing activities over 5 years: stood at -$2.2 million in 2022, then soared by 166.02% to $1.4 million in 2023, then soared by 472.05% to $8.1 million in 2024, then plunged by 57.4% to $3.5 million in 2025, then surged by 44.32% to $5.0 million in 2026.
- Business Quant data shows HIMS's Other financing activities at $5.0 million in Q1 2026, $3.5 million in Q4 2025, and -$958000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Jun 30, 2025 | -958,000.00 |
| Jun 30, 2025 | -958,000.00 |
| Mar 31, 2025 | 3.93 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Sep 30, 2024 | 16.88 Mn |
| Sep 30, 2024 | 16.88 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Jun 30, 2023 | 653,000.00 |
| Jun 30, 2023 | 653,000.00 |